Apogee TherapeuticsAPGE

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$3.1B

Market Cap • 03/05/2024

2023

(há 1 ano)
Fundação

2023

(1 year ago)
IPO

NASDAQ

Listagem
Flag of US

Waltham

Sede • Massachusetts

Valuation

Valuation Indicators

Retorno Histórico

APGESó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

8%

1 dia

30/04/2024

15%

1 semana

26/04/2024

-10%

1 mês

03/04/2024

10 anos

Histórico